First Clinical Experience With ONO-4232: A Randomized, Double-Blind, Placebo-Controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure
Clinical Therapeutics- United States
doi 10.1016/j.clinthera.2016.02.019
Full Text
Abstract
Available in
Categories
Date
May 1, 2016
Authors
Publisher
Elsevier BV